Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intractable diarrhea-choanal atresia-eye anomalies syndrome is characterized by the association of intractable diarrhea of infancy with choanal atresia. Short stature, a prominent and broad nasal bridge, micrognathia, single palmar creases, chronic corneal inflammation, cytopenia, and abnormal hair texture were also reported. So far, the syndrome has been described in three children from the same family. The absence of intellectual deficit and immune deficiency allow this syndrome to be distinguished from other forms of intractable diarrhea of infancy described previously.
Biomarker and diagnostic research for intractable diarrhea-choanal atresia-eye anomalies syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intractable diarrhea-choanal atresia-eye anomalies syndrome.
53 publications have been identified in PubMed for intractable diarrhea-choanal atresia-eye anomalies syndrome. Research spans Case Report / Case Series (45%), Review / Meta-Analysis (20%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 23 | 45% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
10 |
20% |
Laboratory research | 9 | 18% |
Disease patterns and progression | 5 | 10% |
Testing and diagnosis research | 2 | 4% |
Clinical study results | 1 | 2% |
New treatment approaches | 1 | 2% |
Abe J (2026). [PMID: 41601374](https://pubmed.ncbi.nlm.nih.gov/41601374/). *Neuropathology*. [Case Report / Case Series]
Nozawa A (2026). [PMID: 41359887](https://pubmed.ncbi.nlm.nih.gov/41359887/). *J Pediatr Hematol Oncol*. [Basic Science / Preclinical]
Nakamura K (2026). [PMID: 41404351](https://pubmed.ncbi.nlm.nih.gov/41404351/). *Neurol Genet*. [Basic Science / Preclinical]
Samanta D (2026). [PMID: 41548392](https://pubmed.ncbi.nlm.nih.gov/41548392/). *Epilepsy Behav*. [Review / Meta-Analysis]
Resnick O (2026). [PMID: 41684880](https://pubmed.ncbi.nlm.nih.gov/41684880/). *JCEM Case Rep*. [Case Report / Case Series]
Narishige Y (2026). [PMID: 41756285](https://pubmed.ncbi.nlm.nih.gov/41756285/). *Front Immunol*. [Case Report / Case Series]
Juliana CA (2026). [PMID: 41693148](https://pubmed.ncbi.nlm.nih.gov/41693148/). *J Clin Endocrinol Metab*. [Basic Science / Preclinical]
Saito T (2026). [PMID: 41509151](https://pubmed.ncbi.nlm.nih.gov/41509151/). *Clin Pediatr Endocrinol*. [Case Report / Case Series]
Watson CPN (2026). [PMID: 40788267](https://pubmed.ncbi.nlm.nih.gov/40788267/). *Pain*. [Case Report / Case Series]
Kim HJ (2025). [PMID: 40651169](https://pubmed.ncbi.nlm.nih.gov/40651169/). *Epilepsy Res*. [Epidemiology / Natural History]